Rola terapii biologicznej w podtrzymaniu remisji u dzieci z chorobą Leśniowskiego i Crohna | Zendy

Agnieszka Wegner | Zendy; Monika Szychta | Zendy; Jarosław Kierkuś | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rola terapii biologicznej w podtrzymaniu remisji u dzieci z chorobą Leśniowskiego i Crohna

Author(s) -

Agnieszka Wegner,

Monika Szychta,

Jarosław Kierkuś

Publication year - 2013

Publication title -

pediatria polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.136

H-Index - 11

eISSN - 2300-8660

pISSN - 0031-3939

DOI - 10.1016/j.pepo.2012.12.008

Subject(s) - medicine , disease , incidence (geometry) , inflammatory bowel disease , crohn's disease , maintenance therapy , crohn disease , immunology , gastroenterology , dermatology , chemotherapy , physics , optics

In recent years there has been an increase in the incidence of inflammatory bowel disease including Crohn's disease in children. The aim of treatment of Crohn's disease is the induction and maintenance of remission. Currently, it is believed that to achieve healing of the intestinal mucosa may be synonymous with getting complete remission and inhibition of disease progression. Biologics and immunomodulators have a definite place in the treatment of Crohn disease. However, there are no clear guidelines on the efficacy and safety of these two classes of drugs for the children treatment. In addition, questions about the safety of long-term use of biological drugs as well as the best moment of their inclusion needs further reaserch

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research